HCA Healthcare (NYSE:HCA) had its target price boosted by Mizuho from $232.00 to $275.00 in a report published on Wednesday morning, The Fly reports. They currently have a buy rating on the stock.
Several other brokerages have also issued reports on HCA. Deutsche Bank Aktiengesellschaft boosted their price target on HCA Healthcare from $225.00 to $275.00 and gave the company a buy rating in a research note on Wednesday. Citigroup raised their price target on shares of HCA Healthcare from $215.00 to $268.00 and gave the stock a neutral rating in a report on Wednesday. started coverage on shares of HCA Healthcare in a research report on Thursday, May 13th. They set a neutral rating and a $215.00 price objective on the stock. Zacks Investment Research downgraded HCA Healthcare from a buy rating to a hold rating and set a $218.00 price target on the stock. in a research note on Tuesday, June 15th. Finally, Raymond James boosted their price objective on HCA Healthcare from $225.00 to $290.00 and gave the company an outperform rating in a report on Wednesday. Four equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. HCA Healthcare presently has a consensus rating of Buy and an average target price of $231.48.
HCA Healthcare stock opened at $249.25 on Wednesday. The firm has a market capitalization of $82.41 billion, a price-to-earnings ratio of 17.10, a P/E/G ratio of 1.21 and a beta of 1.63. HCA Healthcare has a one year low of $114.38 and a one year high of $254.45. The company has a debt-to-equity ratio of 18.06, a quick ratio of 1.15 and a current ratio of 1.45. The business has a 50 day moving average of $212.68.
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 30th. Shareholders of record on Thursday, September 16th will be given a dividend of $0.48 per share. The ex-dividend date is Wednesday, September 15th. This represents a $1.92 annualized dividend and a dividend yield of 0.77%. HCA Healthcare’s dividend payout ratio is currently 16.54%.
In related news, insider A Bruce Moore, Jr. sold 12,000 shares of the firm’s stock in a transaction dated Monday, May 3rd. The shares were sold at an average price of $205.32, for a total transaction of $2,463,840.00. Following the completion of the sale, the insider now owns 102,381 shares in the company, valued at $21,020,866.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Deborah M. Reiner sold 3,432 shares of the business’s stock in a transaction dated Tuesday, May 11th. The shares were sold at an average price of $208.33, for a total transaction of $714,988.56. Following the completion of the transaction, the senior vice president now owns 6,576 shares in the company, valued at $1,369,978.08. The disclosure for this sale can be found here. Insiders have sold 342,446 shares of company stock valued at $68,773,585 over the last ninety days. 1.60% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in HCA Healthcare by 478.4% during the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 6,600 shares of the company’s stock valued at $1,085,000 after purchasing an additional 5,459 shares during the last quarter. LPL Financial LLC lifted its stake in shares of HCA Healthcare by 13.6% during the 4th quarter. LPL Financial LLC now owns 40,433 shares of the company’s stock valued at $6,650,000 after buying an additional 4,835 shares in the last quarter. Penserra Capital Management LLC raised its holdings in HCA Healthcare by 26.9% during the 4th quarter. Penserra Capital Management LLC now owns 561 shares of the company’s stock valued at $92,000 after acquiring an additional 119 shares during the period. Brown Advisory Inc. bought a new position in shares of HCA Healthcare in the fourth quarter worth $269,000. Finally, Sittner & Nelson LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $41,000. 68.68% of the stock is owned by institutional investors.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Story: Buy Rating
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.